/

Table of contents

Expand All Topics

Constipation

What's new

Updated 2024 ASCRS guidelines for the evaluation and management of chronic constipation .

Background

Overview

Definition
Constipation is a symptom-based disorder defined as fewer than 3 bowel movements per week.
1
Pathophysiology
Constipation is caused by pelvic floor dysfunction, slow colonic transit, metabolic disorders (hypercalcemia, hypothyroidism), medications (opiates, CCBs, antipsychotics), neurological disorders (diabetes mellitus, Parkinson's disease, spinal cord injury), IBS, and primary colonic disorders (strictures, cancer, anal fissure, proctitis).
2
Epidemiology
The overall prevalence of constipation in the US is 16%.
1
Disease course
Anomalous regulation of neuromuscular components within the colon and anorectum, and disruption in the corresponding ascending and descending pathways in the brain-gut axis result in infrequent bowel movements, excessive straining, a sense of incomplete evacuation, failed or lengthy attempts to defecate, digital manipulation to evacuate stools, abdominal bloating, and hard consistency of stools.
2
Prognosis and risk of recurrence
Chronic constipation decreases QoL and ability to function; however, only approximately 25% of patients consult physicians or use medications to manage associated symptoms.
1

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of constipation are prepared by our editorial team based on guidelines from the Japanese Gastroenterological Association (JGA 2025), the American Society of Colon and Rectal Surgeons (ASCRS 2024,2016), the American College of Gastroenterology (ACG/AGA 2023), the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN 2023), the American Academy of Family ...
Show more

Classification and risk stratification

Classification: as per JGA 2025 guidelines, classify primary chronic constipation into the following groups:
functional constipation
IBS-C
motility disorders (small/large intestine type and anorectal type).
⁄
Show 2 more
Create free account

Diagnostic investigations

History and physical examination: as per JGA 2025 guidelines, perform a physical examination, including abdominal examination (visual examination, auscultation, percussion, and palpation) and rectoanal examination (visual examination and DRE), in patients with chronic constipation.
⁄
Show 2 more
Create free account

More topics in this section

  • Laboratory tests

  • Anorectal physiology testing

  • Abdominal imaging

  • Defecography

  • Colonic transit study

Diagnostic procedures

Colonoscopy: as per JGA 2025 guidelines, perform colonoscopy on a case-by-case basis to differentiate secondary constipation.
⁄
Create free account

Medical management

Avoidance of causative agents: as per AGA 2013 guidelines, discontinue medications that can cause constipation, if feasible, before obtaining further testing for constipation.
B
Create free account

More topics in this section

  • Laxatives

  • Secretagogues

  • Ileal bile acid transporter inhibitors

  • Prokinetics

  • Probiotics

Nonpharmacologic interventions

Fiber supplementation: as per JGA 2025 guidelines, offer bulk-forming laxatives in patinets with chronic constipation.
⁄
Create free account

More topics in this section

  • Suppositories and enemas

  • Psychotherapy

Therapeutic procedures

Biofeedback therapy: as per JGA 2025 guidelines, offer biofeedback therapy at specialized centers in patients with chronic constipation caused by pelvic floor dysfunction.
⁄
Create free account

More topics in this section

  • Sacral nerve stimulation

  • Botulinum toxin injections

Surgical interventions

Indications for surgery: as per JGA 2025 guidelines, consider performing antegrade continence enema as a surgical treatment option in specialized centers to avoid colostomy or colon resection surgery for constipation if conservative treatment is ineffective or difficult to continue.
⁄
Show 3 more
Create free account

Specific circumstances

Pediatric patients, diagnosis: as per ESPGHAN/NASPGHAN 2014 guidelines, use the Rome IV criteria for the definition of functional constipation.
E
Show 3 more
Create free account

More topics in this section

  • Pediatric patients (evaluation)

  • Pediatric patients (nonpharmacological management)

  • Pediatric patients (pharmacotherapy)

  • Pediatric patients (therapeutic interventions)

  • Patients with IBS-C (polyethylene glycol)

  • Patients with IBS-C (5-HT4 agonists)

  • Patients with IBS-C (guanylate cyclase activators)

  • Patients with IBS-C (lubiprostone)

  • Patients with IBS-C (tenapanor)

  • Patients with cancer (evaluation)

  • Patients with cancer (prevention)

  • Patients with cancer (abdominal massage)

  • Patients with cancer (laxatives)

  • Patients with cancer (management of fecal impaction)

  • Patients with cancer (elderly)

  • Patients with opioid-induced constipation

Follow-up and surveillance

Evaluation of refractory constipation
As per AGA 2013 guidelines:
Obtain anorectal physiology testing in patients not responding to laxatives.
A
Re-evaluate anorectal physiology and colonic transit in patients with persisting symptoms despite an adequate trial of biofeedback therapy.
B
Create free account